Next Article in Journal
2-Hydroxy-4-(Methylthio)-Mutanoate Supplementation Affects Production, Milk Fatty Acid Profile, and Blood Metabolites of High-Producing Holstein Cows
Previous Article in Journal
Effect of Different Air Oven Temperatures on Chemical, Physical, and Microbial Properties of Dried Bio-Yoghurt Product
Previous Article in Special Issue
Virulence Potential, Biofilm Formation, and Disinfectants Control of Escherichia coli from Raw Milk Bulk Tanks in the Southeast of Brazil
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Antimicrobial Activity of Selected Essential Oils against Staphylococcus aureus from Bovine Mastitis

by
Karen Vanessa Munive Nuñez
1,
Anderson Clayton da Silva Abreu
1,
Jaqueline Milagres de Almeida
1,
Juliano Leonel Gonçalves
2,
Érika Carolina Romão Bonsaglia
3,
Marcos Veiga dos Santos
3 and
Nathália Cristina Cirone Silva
1,*
1
Department of Food Science and Nutrition, School of Food Engineering, University of Campinas (UNICAMP), Campinas 13083-862, Brazil
2
Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USA
3
Department of Animal Nutrition and Production, School of Veterinary Medicine and Animal Sciences, University of São Paulo (USP), Pirassununga 13635-900, Brazil
*
Author to whom correspondence should be addressed.
Dairy 2024, 5(1), 54-65; https://doi.org/10.3390/dairy5010005
Submission received: 6 November 2023 / Revised: 15 November 2023 / Accepted: 2 January 2024 / Published: 5 January 2024
(This article belongs to the Special Issue Microbial Safety of Milk and Dairy Products)

Abstract

:
Staphylococcus aureus is a major cause of subclinical mastitis in dairy cows, and its development of antibiotic resistance has limited treatment efficacy. Essential oils (EOs) are natural products with a wide range of antimicrobial properties that could be used to treat bovine mastitis. This study aims to investigate the antimicrobial activity of EOs against S. aureus isolated from subclinical bovine mastitis cases in the State of São Paulo—Brazil. A total of 14 S. aureus isolates were selected, based on the presence of biofilm-forming genes (icaA, icaD, and bap), and were cultured to a final concentration of 103 CFU.mL−1 for the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) analysis of five EOs (Citrus aurantium bergamia—bergamot, Copaifera reticulata—copaiba, Foeniculum vulgare—fennel, Zingiber officinale—ginger, and Ocimum basilicum—basil). The chemical compositions of the EOs were characterized using gas chromatography coupled with a mass-selective detector (GC/MSD). Basil and bergamot EOs exhibited the highest antimicrobial activity against S. aureus strains, with mean MIC/MBC values of 1.561 ± 0.223/2.806 ± 0.255 mg.mL−1 and 2.782 ± 0.228/4.396 ± 0.198 mg.mL−1, respectively. The primary compounds in basil EO were methyl-chavicol, linalool, and α-humulene, while bergamot EO predominantly contained linalyl acetate, limonene, and linalool. This research highlights the potential of basil and bergamot EOs as natural antimicrobial agents for treating bovine mastitis caused by S. aureus, offering a potential alternative to traditional antibiotics and contributing to animal welfare and public health. In addition, it emphasizes the need for further studies to validate the long-term effects, optimal dosages, and application methods.

1. Introduction

Bovine mastitis, one the most prevalent and costly diseases of dairy cows, is primarily caused by Staphylococcus aureus [1]. This pathogen is a Gram-positive coccus, characterized by its catalase-positive and facultative anaerobic nature, and can grow in a wide range of temperatures as well as pH and water activity levels [2]. It is notably prevalent in Brazil, where it is a leading cause of foodborne outbreaks [3]. It possesses a range of virulence factors, including enzymes, toxins, and survival strategies that facilitate the evasion of host defenses, such as the ability to adhere to surfaces and form biofilms [2,4,5].
Mastitis can be classified into two forms: clinical mastitis, which shows evident signs, such as udder inflammation, redness, warmth, and swelling, representing the cardinal signs of inflammation. Additionally, it leads to visible changes in milk, such as clots and discoloration [6]. The second form is subclinical mastitis (SM), which lacks noticeable signs; however, due to the silent development of the disease, SM has a tendency to progress into chronic infections [7,8]. The effect of mastitis on dairy farms is significant, leading to reduced milk production, increased culling rates, and decreased milk quality [6,9]. Conventional treatments for mastitis primarily depend on antibiotic usage [10]. Unfortunately, the excessive and inappropriate use of antibiotics has contributed to antibiotic resistance in S. aureus, leading to significant hindrances in mastitis treatment. As a result, the efficacy of conventional treatment protocols has been compromised [6,11]. Consequently, there is a growing need to find effective alternatives for mastitis treatments and to reduce the antibiotic resistance problem [8,12].
Plant extracts have emerged as significant therapeutic alternatives, particularly due to the increasing antimicrobial resistance to conventional antibiotics [13]. Throughout the years, common knowledge has proven indispensable for gaining insight into the healing effects of essential oils (EOs). EOs are composed of a complex mixture of volatile molecules, which are specific to each plant, including their range of bioactivities; these molecules include alkaloids, monoterpenes, carotenoids, flavonoids, isoflavones, phenolic acids, oxygen-containing and non-oxygenated terpene hydrocarbons, and aldehydes [13,14]. The mechanisms of antimicrobial activity of EOs include the degradation of the cell wall and cytoplasmic membrane, cytoplasm coagulation, the inhibition of toxic bacterial metabolites, and the inhibition of the bacterial efflux system. However, the efficacy of antimicrobial activity can vary depending on the pathogen and the composition of the EO [15,16,17]. For example, these compounds have a hydrophobic characteristic, which confers greater effectiveness against Gram-positive bacteria. On the other hand, Gram-negative bacteria present lipopolysaccharides that cause rejection of EOs, hindering their absorption and antimicrobial activity [13,16].
The use of EOs as an alternative to treat S. aureus bovine mastitis has not been extensively studied. There is limited research on the topic [17], and further studies are needed to confirm the safety and efficacy of EOs for use in dairy cows. In this context, studies regarding the antimicrobial activity of new compounds, including EOs, especially to develop new treatments against mastitis, are increasingly important [18].
Based on the abovementioned reasons, this study aims to evaluate the antimicrobial activity of five EOs that could be considered potential antimicrobial agents for treating subclinical mastitis caused by S. aureus. It seeks to identify natural compounds relevant to the dairy industry by offering effective and sustainable mastitis treatments.

2. Materials and Methods

2.1. Preparation of Bacterial Strains

Before initiating this study, ethical approval was secured from the Ethical Committee on Animal Use at the School of Veterinary Medicine and Animal Science, University of São Paulo, Brazil, with protocol number 3020/2013. A total of 14 S. aureus strains were initially sourced from raw milk. Samples were collected from cows with SM from commercial dairy herds in the Midwest of São Paulo State, Brazil. The selection criteria for cows were specifically designed to focus on those exhibiting signs of chronic SM, whilst excluding cows with a history of clinical mastitis. Identification of SM was based on consecutive biweekly somatic cell count (SCC) tests and culture-positive results. Specifically, cows were considered to have SM if they had at least two out of three SCC tests with counts exceeding 200,000 cells/mL. These S. aureus strains were sourced from a prior companion study conducted at the Milk Quality Research Laboratory of the University of São Paulo. A comprehensive description is available in previous studies [7,9]. Therefore, the strains were selected based on the presence of biofilm-forming genes (icaA, icaD, and bap). The cultures were stored on nutrient agar slopes at 4 °C until microbiological analysis. Then, bacterial suspensions were prepared by subculturing 100 μL of each strain in 9 mL of brain–heart infusion broth (BHI, Kasvi, Brazil) and incubated at 35 ± 1 °C for 24 h. After this period, inoculum was standardized in sterile 0.85% saline solution to a turbidity of 0.5 on the McFarland scale (equivalent to 1.5 × 108 CFU/mL). For the purpose of this study, bacterial suspensions were adjusted to contain 103 colony-forming units (CFU)/mL.

2.2. Essential Oils

A total of five commercial EOs were purchased from BioEssência® (São Paulo, Brazil). Table 1 describes the characteristics of the EOs evaluated in our study.

2.3. GC/MSD Analysis of EOs

Evaluation of the chemical composition of EOs was performed at the Multidisciplinary Center of Chemical, Biological and Agricultural Research (CPQBA) of UNICAMP using an HP-6890 gas chromatograph coupled with an HP-5975 mass-selective detector (GC/MSD). The analyses were carried out using the following analytical conditions: HP-5MS capillary column (30 m × 0.25 mm × 0.25 μm); injector temperature of 220 °C; column temperatures of 60 °C, 3 °C/min, and 240 °C; and detector temperature of 250 °C. The injected volume was 1 μL, and the carrier gas was helium at a 1 mL/min−1 flow rate and a 40:1 split ratio. Identification of the analytes was performed by comparing their retention indices (IR) using coinjection of a mixture of hydrocarbon standards (C-8 to C-24) with the electronic equipment’s database from the National Institute of Standards and Technology (NIST-11) [19] and available literature data [20].

2.4. Determination of Minimum Inhibitory Concentrations (MIC)

The determination of broth microdilution was performed using the microdilution technique. Initially, an evaluation of EO density was performed in triplicate to determine the volume of EO stock solution needed to achieve the desired concentration based on the relationship between mass and volume. For the MIC procedures, 360 μL of TSB broth (Tryptone Soy Broth) was dispensed into the first column of a 96-well acrylic plate, along with 0.5% Tween 80 and 40 μL of essential oil, reaching a final concentration of 10% of essential oil in the first well. Then, 200 μL of TSB broth with 0.5% Tween 80 was distributed into the wells of the following columns. After homogenization of the contents in the wells of the first column, two-fold serial dilution was performed. An aliquot of 200 μL of the mixture from the first well of the row was transferred into the second well, and so on, consecutively. Subsequently, the strains were standardized to the McFarland scale and adjusted with sterile saline to a concentration of 105 CFU/mL, and 2 μL of the microbial suspension obtained was inoculated, reaching a final concentration of 103 CFU/mL per well. The microplates were incubated at 37 °C for 24 h. Afterward, growth confirmation was carried out in the wells by applying 50 μL of resazurin solution with a concentration of 0.01%, and then, waiting ~5 to 10 min to perform a visual reading of the occurrence of a colorimetric reaction, and an evaluation of the growth inhibition of microorganisms [21,22]. All tests were performed in triplicate. The MIC was calculated according to the well with the lowest concentration of essential oil that presented a blue color, which indicates the absence of microbial growth.

2.5. Determination of the Minimum Bactericidal Concentration (MBC)

To determine the minimum bactericidal concentration, 10 μL was removed from the MIC and the three previous wells and subsequently deposited on nutrient agar plates using the micro-drop technique. Later, the plates were incubated at 37 °C for 24 h. At the end of incubation, a reading was performed, and the following criteria were considered: sections with microbial growth indicated bacteriostatic activity of the essential oil in question at the analyzed concentration, and sections with no microbial growth showed bactericidal activity. The well with the lowest concentration that exhibited a bactericidal effect was recorded as having MBC [23].

2.6. Statistical Analysis

Data are reported as the mean ± standard deviation (SD) of three measurements. Statistical analysis to evaluate the difference between groups was performed using the analysis of variance (ANOVA), followed by Tukey’s range test to analyze data, with the significance level set at p < 0.05. All statistical analyses were performed using SPSS Statistics 21 software (IBM Corp., Armonk, NY, USA) [24].

3. Results

3.1. Chemical Composition of the Essential Oils

The compositions of the EOs obtained through GC/MSD analysis are presented in Table 2, and their chromatograms are shown in Figure 1. Among the several chemical components found in bergamot EO, linalyl acetate, limonene, and linalool were the most abundant compounds (accounting for 39.18%, 29.88%, and 16.91%, respectively). Sesquiterpenes were found to be the major compound of ginger EO, containing mainly alpha-zingiberene (32.76%), ar-curcumene (14.03%), and β-sesquiphellandrene (12.95%). Basil EO presented phenylpropanoids, monoterpenes, and sesquiterpenes, especially methyl-chavicol (72.86%), linalool (18.76%), and α-humulene (1.55%), as its major compounds. Copaiba oil was rich in sesquiterpenes, containing mainly trans-caryophyllene (47.43%), α-humulene (7.95%), α-trans-bergamotene (7.59%), and α-copaene (6.81%). Fennel EO contained mainly a combination of monoterpenes and phenylpropanoids, with trans-anethole (81.36%), followed by fenchone (5.84%) and α-pinene (4.56%), being the primary compounds.
In order to provide a comprehensive overview of the chemical compositions of the essential oils examined in this study, we grouped the identified compounds into their respective chemical classes based on the information delineated in Table 2. For Bergamot EO, monoterpenes emerged as the most abundant class, making up roughly 56.72% of the total composition. This was followed by esters, which contributed around 40.66%. Alcohols and aldehydes were present but less abundant, constituting approximately 1.06% and 1.55%, respectively. Copaiba EO was characterized by sesquiterpenes, accounting for 86.36% of the overall composition. Oxygenated sesquiterpenes made up a smaller fraction, approximately 0.59%. Compounds designated as ‘M = 204’ comprised about 2.18% of the EO composition. In the case of Fennel EO, phenylpropanoids were overwhelmingly dominant, contributing to about 82.62% of the total composition. Monoterpenes followed, accounting for roughly 11.00%, while sesquiterpenes were minimally present, constituting about 0.21%. For Ginger EO, sesquiterpenes were the major class, making up approximately 73.09% of the total oil composition. Monoterpenes were also significant, contributing about 13.89%. Oxygenated monoterpenes and aldehydes were found in smaller amounts, representing 2.27% and 0.28%, respectively. Lastly, basil EO was primarily composed of phenylpropanoids, which accounted for 73.62% of the total composition. Monoterpenes comprised the second largest category, contributing about 21.57%, while sesquiterpenes were found in smaller proportions, around 2.25% of the total composition.

3.2. Antimicrobial Activity of EOs against S. aureus

The antimicrobial activity of the EOs was evaluated using MIC and MBC tests. The results of the mean values are shown in Figure 2.
Based on the antimicrobial activity results, the EOs displayed varying levels of effectiveness against S. aureus strains, with a clear decreasing order of activity: basil EO > bergamot EO > copaiba EO > ginger EO > fennel EO.
The two most effective EOs were basil and bergamot, with mean MIC/MBC values of 1.561 ± 0.223/2.806 ± 0.255 and 2.782 ± 0.228/4.396 ± 0.198 mg.mL−1, respectively. These EOs exhibited higher antimicrobial activity against S. aureus isolates than copaiba and ginger EOs, which had mean MIC/MBC values of 6.541 ± 1.705/13.637 ± 1.903 and 18.58 ± 2.138/24.341 ± 2.631 mg.mL−1, respectively. Fennel EO had the highest MIC values, with a mean of 34.02 ± 2.083 mg.mL−1, and did not exhibit a bactericidal effect, even at the highest concentration applied.
Concerning the results of the MIC/MBC tests for each S. aureus strain, they are displayed in Supplementary Figures S1 and S2, respectively. The MIC/MBC values of basil and bergamot EOs ranged between 0.149–2.378/0.298–4.755 and 0.277–4.435/1.109–8.87 mg.mL−1, respectively. Copaiba and ginger EOs had MIC/MBC values ranging between 1.11–17.76/4.44–35.52 and 4.605–36.84/9.21–36.84 mg.mL−1, respectively. The MIC values of fennel EO ranged from 19.44 to 38.88 mg/mL−1.
Furthermore, when comparing the antimicrobial activity of the EOs, basil emerged as the most effective EO, demonstrating significantly lower MIC and MBC against Staphylococcus aureus. Bergamot, fennel, ginger, and copaiba showed no significant difference in their antimicrobial activities.

4. Discussion

Bovine mastitis, associated with S. aureus infection, requires preventive measures in dairy farming [6,9,10]. Managing bovine mastitis presents a formidable challenge, mainly due to the biofilm-forming capabilities of S. aureus, facilitated by genes such as icaA, icaD, and bap. These genes enable the bacteria to firmly attach to the bovine mammary epithelium and form biofilms, which can enhance bacterial resistance to antimicrobial agents, often leading to persistent and recurrent infections [25,26]. In light of this, our isolate selection was strategic, aiming to assess the antimicrobial potency of EOs as agents against S. aureus, even in the presence of genes capable of forming biofilms.
The overuse of antibiotics has led to resistance in pathogens [11,27], driving the search for alternative treatments without exacerbating antibiotic resistance [8,18]. Several studies have shown that the chemical constituents of EOs are abundant in aromatic compounds, which can be classified into two structural groups: terpenoids and phenylpropanoids [13,17]. These phenolic compounds of EOs can modify the permeability of the cell membrane by penetrating the phospholipids bilayer of the bacterial cell wall [28]. In our study, it was observed that among the tested EOs, basil EO exhibited the highest antimicrobial activity, with low MIC/MBC, which indicates their ability to inhibit and kill S. aureus at relatively low concentrations. The phenolic compounds and monoterpenes found as the major components of these EOs must be associated with their antimicrobial properties (72.86%). Supporting our findings, Falowo et al. [29] reported that basil EO contains bioactive chemicals such as estragole (41.40%), 1,6-octadien-3-ol, 3.7-dimethyl (29.49%), and bergamotene (5.32%). Based on these observations, we hypothesize that the presence of estragole and other bioactive compounds in basil EO plays a crucial role in its remarkable antimicrobial activity against S. aureus strains.
Terpenes and terpenoids represent the most active phytochemicals studied, with properties for treating or preventing diseases, followed by polyphenols (such as phenolic acids and flavonoids) [16,30]. Our findings support these claims, as these compounds, constituting up to 90% of most EO compositions, exhibit diverse chemical and biological properties [28]. Our study reported that bergamot EO was found to be the second most effective antimicrobial agent against S. aureus strains according to the MIC/MBC results. Among the several chemical components contained in this EO, monoterpenes such as linalyl acetate (39.18%), limonene (29.88%), and linalool (16.91%) were found to be the most abundant. A study performed to discover the biological activities of bergamot EO suggested good antimicrobial activity against S. aureus, and identified d-limonene (60.44%) and γ-terpinene (20.28%) as the major compounds contributing to this activity [24]. The significant presence of these active compounds, particularly the monoterpenes, in bergamot EO may account for its notable antimicrobial properties.
It is important to note that the antimicrobial activity of EOs can vary depending on the specific pathogen and the composition of the EO. For instance, EOs of basil and bergamot were found to be active against Gram-positive bacteria (S. aureus and B. subtilis). On the other hand, perilla EO strongly inhibited yeast growth [31], adding complexity to the application of EOs as antimicrobial agents. While our results are promising, indicating that basil and bergamot EOs could be helpful in treating S. aureus infections in subclinical bovine mastitis, more research is needed. Their low MIC and MBC values indicate that they could help control the growth of S. aureus in milk, thereby reducing the risk of mastitis in dairy cows. However, further research must corroborate these findings, and the safety and efficacy of using EOs in dairy cows must be thoroughly evaluated. Future studies should focus on assessing the long-term effects of EO treatment, including appropriate dosage, application methods, and potential interactions with other medications or treatments. It is essential to ensure these compounds’ safe and effective management in bovine mastitis, without negatively impacting milk quality or human health.
Sesquiterpenes are well known for their bioactive properties that display good inhibitory activity against S. aureus [32]. Copaiba EO varies in its phytochemical composition depending on its species. The primary components include sesquiterpenes, diterpenes, and β-caryophyllene [33]. In line with this, our results demonstrated a high concentration of sesquiterpenes in the tested copaiba EO, containing mainly trans-caryophyllene (47.43%), α-humulene (7.95%), α-trans-bergamotene (7.59%), and α-copaene (6.81%). These findings support the research conducted by de Faria et al. [34], who also identified sesquiterpenes as the major compound in Copaiba EO and showed its antimicrobial activity against coagulase-negative Staphylococcus. Overall, our results reinforce that sesquiterpenes are bioactive compounds responsible for the observed antimicrobial activity against the strains we tested.
Studies have shown that Ginger EO can help prevent the growth of various pathogens by targeting the bacterial cell membrane and genetic material [13,35]. Although Ginger EO exhibits some antimicrobial activity against S. aureus strains, its efficacy appears to be comparatively lower when compared to the other EOs tested in our study. Sesquiterpenes were the primary compound of this EO, mainly containing α-zingiberene, ar-curcumene, and β-sesquiphellandrene. In line with our findings, Dal Pozzo et al. [36] evaluated the activity of EOs from various plants, including ginger, basil, rosemary, and sage EO, along with the major compound cineole, and reported no antimicrobial activity against S. aureus. While ginger EO exhibits some antimicrobial effects, our study confirms that it has lower efficacy compared to the other tested EOs.
Based on the MIC results, fennel EO, predominantly composed of monoterpenes and phenylpropanoids, exhibited minimal activity and showed no activity in the MBC test against most of the tested S. aureus strains. Interestingly, our results concerning fennel EO diverge from some of the existing literature. In comparison, some studies have reported its antimicrobial potential [37,38]. Likewise, Kwiatkowski et al. [39] demonstrated that trans-anethole at a concentration of 4% displayed antistaphylococcal effects. However, our results are consistent with those of Rani et al. [40], who determined that fennel EO has an insignificant impact on S. aureus. Overall, these findings suggest that fennel EO may not be a potent solution for fighting against S. aureus that have biofilm-forming genes (e.g., icaA, icaD, and bap, such as in the current study).
Above all, and based on previous studies that report that EO compounds represent the main source of chemical diversity [13,16,32], we support the relevance of the current finding that includes natural compounds’ biological properties. The discovery of these antimicrobial agents against S. aureus, which causes bovine mastitis, may have several benefits not only in the dairy industry but also for the pharmaceutical and medical industries. In addition, this study offers practical benefits for dairy breeders. Using EOs as an antibiotic alternative could align with sustainable farming practices. This is especially valuable in the current context of increased antibiotic resistance, and consumer preference for natural treatments. These insights contribute to improved herd health, milk quality, and overall farm sustainability. Given the rich source of chemical diversity in EOs, future studies should focus on key bioactive elements in EOs with proven efficacy against S. aureus. Additionally, further studies are needed to confirm the safety and effectiveness of EOs for use in dairy cows with bovine mastitis, and evaluate appropriate dosages and application methods. In this context, ensuring that EOs do not negatively impact milk quality or human health becomes essential.

5. Conclusions

In conclusion, our study reported that basil and bergamot are the most efficient antimicrobial EOs among the five EOs tested against S. aureus causing bovine mastitis. The phenylpropanoid compounds and monoterpenes found to be the major components of these EOs must be associated with their antimicrobial properties. This study contributes to the development of potential alternatives to conventional antibiotics, as an approach to mitigate the challenges posed by antibiotic-resistant S. aureus.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/dairy5010005/s1, Figure S1: Minimum inhibitory concentration results of EOs tested against S. aureus strains, Figure S2: Minimum bactericidal concentration results of EOs tested against S. aureus strains.

Author Contributions

Conceptualization, N.C.C.S. and K.V.M.N.; methodology, K.V.M.N., A.C.d.S.A. and J.M.d.A.; formal analysis, K.V.M.N.; investigation, K.V.M.N., A.C.d.S.A., J.L.G., J.M.d.A. and É.C.R.B.; resources, J.L.G., M.V.d.S. and N.C.C.S.; data curation, K.V.M.N.; writing—original draft preparation, K.V.M.N.; writing—review and editing, J.M.d.A., J.L.G., M.V.d.S., É.C.R.B. and N.C.C.S.; supervision, N.C.C.S.; project administration, N.C.C.S.; funding acquisition, K.V.M.N., M.V.d.S. and N.C.C.S. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by a Ph.D. fellowship from the Brazilian government through the National Council for Scientific and Technological Development (CNPq—grant numbers 141320/2018–4) and the Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES—grant number 001).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data is contained within the article.

Acknowledgments

We would like to acknowledge Adilson Sartoratto for his invaluable support in the GC/MSD analyses conducted at CPQBA, UNICAMP. Additionally, we extend our gratitude to the National Council for Scientific and Technological Development (CNPq) for providing the PhD fellowship that supported this research.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
EOEssential oil
MICMinimum inhibitory concentration
MBCMinimum bactericidal concentration
GC/MSDGas chromatography coupled with a mass-selective detector
CFU/mLColony-forming units per milliliter
SMSubclinical mastitis
SCCSomatic cell count
BHIBrain–heart infusion broth
SDStandard deviation
ANOVAAnalysis of variance

References

  1. Zaatout, N.; Ayachi, A.; Kecha, M. Staphylococcus Aureus Persistence Properties Associated with Bovine Mastitis and Alternative Therapeutic Modalities. J. Appl. Microbiol. 2020, 129, 1102–1119. [Google Scholar] [CrossRef] [PubMed]
  2. Bhunia, A.K. Staphylococcus Aureus. In Foodborne Microbial Pathogens; Springer: New York, NY, USA, 2018; pp. 181–192. ISBN 978-0-387-74536-7. [Google Scholar]
  3. da Silva, A.C.; Rodrigues, M.X.; Silva, N.C.C. Methicillin-Resistant Staphylococcus Aureus in Food and the Prevalence in Brazil: A Review. Braz. J. Microbiol. 2020, 51, 347–356. [Google Scholar] [CrossRef] [PubMed]
  4. Jenul, C.; Horswill, A.R. Regulation of Staphylococcus Aureus Virulence. Microbiol. Spectr. 2019, 7. [Google Scholar] [CrossRef] [PubMed]
  5. Zhu, X.; Liu, D.; Singh, A.K.; Drolia, R.; Bai, X.; Tenguria, S.; Bhunia, A.K. Tunicamycin Mediated Inhibition of Wall Teichoic Acid Affects Staphylococcus Aureus and Listeria Monocytogenes Cell Morphology, Biofilm Formation and Virulence. Front. Microbiol. 2018, 9, 1352. [Google Scholar] [CrossRef] [PubMed]
  6. Sharun, K.; Dhama, K.; Tiwari, R.; Gugjoo, M.B.; Iqbal Yatoo, M.; Patel, S.K.; Pathak, M.; Karthik, K.; Khurana, S.K.; Singh, R.; et al. Advances in Therapeutic and Managemental Approaches of Bovine Mastitis: A Comprehensive Review. Vet. Q. 2021, 41, 107–136. [Google Scholar] [CrossRef] [PubMed]
  7. Gonçalves, J.L.; Kamphuis, C.; Vernooij, H.; Araújo, J.P.; Grenfell, R.C.; Juliano, L.; Anderson, K.L.; Hogeveen, H.; Dos Santos, M.V. Pathogen Effects on Milk Yield and Composition in Chronic Subclinical Mastitis in Dairy Cows. Vet. J. 2020, 262, 105473. [Google Scholar] [CrossRef] [PubMed]
  8. Tomanić, D.; Samardžija, M.; Kovačević, Z. Alternatives to Antimicrobial Treatment in Bovine Mastitis Therapy: A Review. Antibiotics 2023, 12, 683. [Google Scholar] [CrossRef]
  9. Gonçalves, J.L.; Kamphuis, C.; Martins, C.M.M.R.; Barreiro, J.R.; Tomazi, T.; Gameiro, A.H.; Hogeveen, H.; dos Santos, M.V. Bovine Subclinical Mastitis Reduces Milk Yield and Economic Return. Livest. Sci. 2018, 210, 25–32. [Google Scholar] [CrossRef]
  10. Ruegg, P.L. A 100-Year Review: Mastitis Detection, Management, and Prevention. J. Dairy Sci. 2017, 100, 10381–10397. [Google Scholar] [CrossRef]
  11. da Silva Abreu, A.C.; Matos, L.G.; da Silva Cândido, T.J.; Barboza, G.R.; de Souza, V.V.M.A.; Munive Nuñez, K.V.; Cirone Silva, N.C. Antimicrobial Resistance of Staphylococcus Spp. Isolated from Organic and Conventional Minas Frescal Cheese Producers in São Paulo, Brazil. J. Dairy Sci. 2021, 104, 4012–4022. [Google Scholar] [CrossRef]
  12. Cheng, W.N.; Han, S.G. Bovine Mastitis: Risk Factors, Therapeutic Strategies, and Alternative Treatments—A Review. Asian-Australas. J. Anim. Sci. 2020, 33, 1699. [Google Scholar] [CrossRef] [PubMed]
  13. Ni, Z.J.; Wang, X.; Shen, Y.; Thakur, K.; Han, J.; Zhang, J.G.; Hu, F.; Zhao, J.W. Recent Updates on the Chemistry, Bioactivities, Mode of Action, and Industrial Applications of Plant Essential Oils. Trends Food Sci. Technol. 2021, 110, 78–89. [Google Scholar] [CrossRef]
  14. Tavares, L.; Zapata Noreña, C.P.; Barros, H.L.; Smaoui, S.; Lima, P.S.; Marques de Oliveira, M. Rheological and Structural Trends on Encapsulation of Bioactive Compounds of Essential Oils: A Global Systematic Review of Recent Research. Food Hydrocoll. 2022, 129, 107628. [Google Scholar] [CrossRef]
  15. Man, A.; Santacroce, L.; Jacob, R.; Mare, A.; Man, L. Antimicrobial Activity of Six Essential Oils against a Group of Human Pathogens: A Comparative Study. Pathogens 2019, 8, 15. [Google Scholar] [CrossRef] [PubMed]
  16. Álvarez-Martínez, F.J.; Barrajón-Catalán, E.; Herranz-López, M.; Micol, V. Antibacterial Plant Compounds, Extracts and Essential Oils: An Updated Review on Their Effects and Putative Mechanisms of Action. Phytomedicine 2021, 90, 153626. [Google Scholar] [CrossRef] [PubMed]
  17. Caneschi, A.; Bardhi, A.; Barbarossa, A.; Zaghini, A. Plant Essential Oils as a Tool in the Control of Bovine Mastitis: An Update. Molecules 2023, 28, 3425. [Google Scholar] [CrossRef] [PubMed]
  18. Lopes, T.S.; Fontoura, P.S.; Oliveira, A.; Rizzo, F.A.; Silveira, S.; Streck, A.F. Use of Plant Extracts and Essential Oils in the Control of Bovine Mastitis. Res. Vet. Sci. 2020, 131, 186–193. [Google Scholar] [CrossRef]
  19. National Institute of Standards and Technology. NIST Chemistry WebBook SRD 69. Available online: https://webbook.nist.gov/ (accessed on 10 October 2021).
  20. Adams, R.P. Identification of Essential Oil Components by Gas Chromatography/Mass Spectrometry, 4th ed.; Allured Publ.: Carol Stream, IL, USA, 2007; ISBN 978-1932633214. [Google Scholar]
  21. Da Silva, A.C.; Iacuzio, R.; Da Silva Cândido, T.J.; Xavier Rodrigues, M.; Cirone Silva, N.C. Resistência Antimicrobiana De Salmonella Spp., Staphylococcus Aureus E Escherichia Coli Isolados De Carcaças De Frangos: Resistência A Antibióticos E Óleos Essenciais. Rev. Bras. Agropecuária Sustentável 2018, 8, 95–103. [Google Scholar] [CrossRef]
  22. de Souza, V.V.M.A.; Crippa, B.L.; de Almeida, J.M.; Iacuzio, R.; Setzer, W.N.; Sharifi-Rad, J.; Silva, N.C.C. Synergistic Antimicrobial Action and Effect of Active Chitosan-Gelatin Biopolymeric Films Containing Thymus Vulgaris, Ocimum Basilicum and Origanum Majorana Essential Oils against Escherichia Coli and Staphylococcus Aureus. Cell. Mol. Biol. 2020, 66, 214–223. [Google Scholar] [CrossRef]
  23. Knezevic, P.; Aleksic, V.; Simin, N.; Svircev, E.; Petrovic, A.; Mimica-Dukic, N. Antimicrobial Activity of Eucalyptus Camaldulensis Essential Oils and Their Interactions with Conventional Antimicrobial Agents against Multi-Drug Resistant Acinetobacter Baumannii. J. Ethnopharmacol. 2016, 178, 125–136. [Google Scholar] [CrossRef]
  24. Xing, C.; Qin, C.; Li, X.; Zhang, F.; Linhardt, R.J.; Sun, P.; Zhang, A. Chemical Composition and Biological Activities of Essential Oil Isolated by HS-SPME and UAHD from Fruits of Bergamot. LWT 2019, 104, 38–44. [Google Scholar] [CrossRef]
  25. Campos, B.; Pickering, A.C.; Rocha, L.S.; Aguilar, A.P.; Fabres-Klein, M.H.; de Oliveira Mendes, T.A.; Fitzgerald, J.R.; Ribon, A. Diversity and Pathogenesis of Staphylococcus Aureus from Bovine Mastitis: Current Understanding and Future Perspectives. BMC Vet. Res. 2022, 18, 115. [Google Scholar] [CrossRef] [PubMed]
  26. Silva, V.; Almeida, L.; Gaio, V.; Cerca, N.; Manageiro, V.; Caniça, M.; Capelo, J.L.; Igrejas, G.; Poeta, P. Biofilm Formation of Multidrug-Resistant Mrsa Strains Isolated from Different Types of Human Infections. Pathogens 2021, 10, 970. [Google Scholar] [CrossRef] [PubMed]
  27. Munive Nuñez, K.V.; da Silva Abreu, A.C.; Gonçalves, J.L.; dos Santos, M.V.; de Oliveira Rocha, L.; Cirone Silva, N.C. Virulence and Antimicrobial Resistance Genes Profiles of Spa Type T605 Methicillin-Susceptible Staphylococcus Aureus Isolated from Subclinical Bovine Mastitis. J. Appl. Microbiol. 2023, 134, lxad057. [Google Scholar]
  28. Sakkas, H.; Papadopoulou, C. Antimicrobial Activity of Basil, Oregano, and Thyme Essential Oils. J. Microbiol. Biotechnol. 2017, 27, 429–438. [Google Scholar] [CrossRef] [PubMed]
  29. Falowo, A.B.; Mukumbo, F.E.; Idamokoro, E.M.; Afolayan, A.J.; Muchenje, V. Phytochemical Constituents and Antioxidant Activity of Sweet Basil (Ocimum Basilicum L.) Essential Oil on Ground Beef from Boran and Nguni Cattle. Int. J. Food Sci. 2019, 2019, 2628747. [Google Scholar] [CrossRef]
  30. Masyita, A.; Mustika Sari, R.; Dwi Astuti, A.; Yasir, B.; Rahma Rumata, N.; Emran, T.B.; Nainu, F.; Simal-Gandara, J. Terpenes and Terpenoids as Main Bioactive Compounds of Essential Oils, Their Roles in Human Health and Potential Application as Natural Food Preservatives. Food Chem. X 2022, 13, 100217. [Google Scholar] [CrossRef] [PubMed]
  31. Lv, F.; Liang, H.; Yuan, Q.; Li, C. In Vitro Antimicrobial Effects and Mechanism of Action of Selected Plant Essential Oil Combinations against Four Food-Related Microorganisms. Food Res. Int. 2011, 44, 3057–3064. [Google Scholar] [CrossRef]
  32. Bagheri, L.; Khodaei, N.; Salmieri, S.; Karboune, S.; Lacroix, M. Correlation between Chemical Composition and Antimicrobial Properties of Essential Oils against Most Common Food Pathogens and Spoilers: In-Vitro Efficacy and Predictive Modelling. Microb. Pathog. 2020, 147, 104212. [Google Scholar] [CrossRef]
  33. de Oliveira, D.F.F.; Nascimento, T.P.; Rodrigues, C.H.; Batista, J.M.S.; Liu, T.P.S.L.; De Medeiros, E.S.; Mota, R.A.; Costa, R.M.P.B.; Porto, T.S.; Porto, C.S.; et al. Antimicrobial Potential of Copaiba Oil (Copaifera Multijuga Hayne-Leguminosae) against Bubaline Mastitis Multiresistant Isolates. An. Acad. Bras. Cienc. 2020, 92, e20200521. [Google Scholar] [CrossRef]
  34. de Faria, M.J.M.; Braga, C.A.d.S.B.; de Paula, J.R.; André, M.C.D.P.B.; Vaz, B.G.; de Carvalho, T.C.; Romão, W.; Costa, H.B.; Conceição, E.C. Antimicrobial Activity of Copaifera Spp. Against Bacteria Isolated from Milk of Cows with Mastitis. Cienc. Anim. Bras. 2017, 18, e39068. [Google Scholar] [CrossRef]
  35. Wang, X.; Shen, Y.; Thakur, K.; Han, J.; Zhang, J.G.; Hu, F.; Wei, Z.J. Antibacterial Activity and Mechanism of Ginger Essential Oil against Escherichia Coli and Staphylococcus Aureus. Molecules 2020, 25, 3955. [Google Scholar] [CrossRef] [PubMed]
  36. Dal Pozzo, M.; Santurio, D.F.; Rossatto, L.; Vargas, A.C.; Alves, S.H.; Loreto, E.S.; Viegas, J. Activity of Essential Oils from Spices against Staphylococcus Spp. Isolated from Bovine Mastitis. Arq. Bras. Med. Veterinária e Zootec. 2011, 63, 1229–1232. [Google Scholar] [CrossRef]
  37. Ghasemian, A.; Al-Marzoqi, A.H.; Mostafavi, S.K.S.; Alghanimi, Y.K.; Teimouri, M. Chemical Composition and Antimicrobial and Cytotoxic Activities of Foeniculum Vulgare Mill Essential Oils. J. Gastrointest. Cancer 2020, 51, 260–266. [Google Scholar] [CrossRef]
  38. Moreira Gonçalves, S.; Gomes Motta, J.F.; Ribeiro-Santos, R.; Hidalgo Chávez, D.W.; Ramos de Melo, N. Functional and Antimicrobial Properties of Cellulose Acetate Films Incorporated with Sweet Fennel Essential Oil and Plasticizers. Curr. Res. Food Sci. 2020, 3, 1–8. [Google Scholar] [CrossRef]
  39. Kwiatkowski, P.; Pruss, A.; Masiuk, H.; Mnichowska-Polanowska, M.; Kaczmarek, M.; Giedrys-Kalemba, S.; Dołęgowska, B.; Zielińska-Bliźniewska, H.; Olszewski, J.; Sienkiewicz, M. The Effect of Fennel Essential Oil and Trans-Anethole on Antibacterial Activity of Mupirocin against Staphylococcus Aureus Isolated from Asymptomatic Carriers. Postep. Dermatologii Alergol. 2019, 36, 308–314. [Google Scholar] [CrossRef]
  40. Rani, B.; Naz, S.; Saeed, S.; Manan, A.; Chatha, M. Antibacterial Effects of Common Spices against Staphylococcus Aureus under Laboratory Conditions. Biosci. Rev. 2021, 3, 6–16. [Google Scholar] [CrossRef]
Figure 1. Chromatographic profiles of EOs tested via GC/MSD. The area represented by the peaks corresponds to each component’s proportions in the mixture. (a) Bergamot EO; (b) copaiba EO; (c) ginger EO; (d) fennel EO; (e) basil EO.
Figure 1. Chromatographic profiles of EOs tested via GC/MSD. The area represented by the peaks corresponds to each component’s proportions in the mixture. (a) Bergamot EO; (b) copaiba EO; (c) ginger EO; (d) fennel EO; (e) basil EO.
Dairy 05 00005 g001
Figure 2. Minimum inhibitory concentration and minimum bactericidal concentration results of EOs tested against S. aureus strains. Bars represent mean ± SD. Means with different letters are significantly different (p < 0.05).
Figure 2. Minimum inhibitory concentration and minimum bactericidal concentration results of EOs tested against S. aureus strains. Bars represent mean ± SD. Means with different letters are significantly different (p < 0.05).
Dairy 05 00005 g002
Table 1. Botanical and geographical characteristics of EOs.
Table 1. Botanical and geographical characteristics of EOs.
Botanical OriginsPlant FamilyCommon Names of EOsGeographical Origin
Citrus aurantium bergamiaRutaceaeBergamotBrazil
Copaifera reticulataFabaceaeCopaibaBrazil
Foeniculum vulgareApiaceaeFennelBrazil
Zingiber officinaleZingiberaceaeGingerBrazil
Ocimum basilicumLamiaceaeBasilBrazil
Table 2. Chemical composition of EOs identified by GC/MSD.
Table 2. Chemical composition of EOs identified by GC/MSD.
Essential OilRIRI (Lit.)Compound% Rel.
Bergamot932932α-pinene0.56
971969sabinene0.59
975974β-pinene3.49
989988β-myrcene0.77
10231020p-cymene0.69
10291029Limonene29.88
10571054γ-terpinene3.83
11021095Linalool16.91
12271227nerol (cis-geraniol)1.06
12391238neral (cis-citral)0.69
12581257Linalyl acetate39.18
12691267geranial (trans-citral)0.86
13721423linalyl butyrate1.48
Copaiba13351335δ-elemen0.67
13471495α-cubebene1.36
13741374α-copaene6.81
13881387β-cubebene0.44
13901389β-elemene1.75
13961398cyperene0.54
14211419trans-caryophyllene47.43
14321434γ-elemene2.04
14351432α-trans-bergamotene7.59
14521452α-humulene7.95
14561454trans-β-farnesene0.36
14581458allo-aromadendrene0.43
14751478γ-muurolene2.43
14791484germacrene D5.69
1483-M = 2041.59
14921493epi-cubebol1.04
14931500bicyclogermacrene0.75
14971500α-muurolene0.66
15071505β-bisabolene4.11
15111513γ-cadinene0.6
15211522δ-cadinene4.11
1541-M = 2040.59
15791582caryophyllene oxide0.59
16141618junenol0.46
Fennel932932α-pinene4.56
975974β-pinene0.55
989988β-myrcene0.59
10041002α-phellandrene3.55
10231020p-cymene0.34
10271029limonene1.2
10561054γ-terpinene0.21
10881086fenchone5.84
11971195p-allylanisole (estragole)0.97
12511249cis-anethole0.63
12911282trans-anethole81.36
14781484germacrene D0.21
Ginger800801hexanal0.28
932932α-pinene1.66
947946camphene5.01
9849816-methyl-5-hepten-2-one0.31
989988β-myrcene0.57
10281029limonene4.88
103010261,8-cineole (eucalyptol)2.27
11641165endo-borneol1.13
1174-M = 1660.24
11891186α-terpineol0.54
13731374α-copaene0.74
13821379geranyl-acetate0.42
13901389β-elemene1.17
14041405sesquitujene0.37
14311434γ-elemen0.45
14551454trans-β-farnesene0.42
14781478γ-muurolene1.75
14831479ar-curcumene14.03
14901496valenceno1.58
14981493α-zingiberene32.76
15091505β-bisabolene11.72
151615207-epi-α-selenene0.62
15251521β-sesquiphellandrene12.95
15311529trans-γ-bisabolene0.39
15471548elemol0.51
15621561trans-nerolidol0.56
1587-M = 2220.34
1611-M = 2220.77
1628-M = 2220.53
1685-M = 2220.56
1692-M = 2200.48
Basil971969sabinene0.57
10151014α-terpinene0.32
10231020p-cymene0.71
10561054γ-terpinene0.69
1087-n.i.0.37
11011095linalool18.76
11711167menthol0.61
11761174terpin-4-ol0.82
12021195p-allylanisole (estragole)72.86
12691264trans-citral (geranial)0.64
14331432α-trans-bergamotene0.7
15411452α-humulene1.55
15631562trans-methoxycinnamaldehyde0.76
1565-M = 1640.64
RI: retention index. RI (Lit.): retention index from literature data [20].
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Munive Nuñez, K.V.; Abreu, A.C.d.S.; Almeida, J.M.d.; Gonçalves, J.L.; Bonsaglia, É.C.R.; dos Santos, M.V.; Silva, N.C.C. Antimicrobial Activity of Selected Essential Oils against Staphylococcus aureus from Bovine Mastitis. Dairy 2024, 5, 54-65. https://doi.org/10.3390/dairy5010005

AMA Style

Munive Nuñez KV, Abreu ACdS, Almeida JMd, Gonçalves JL, Bonsaglia ÉCR, dos Santos MV, Silva NCC. Antimicrobial Activity of Selected Essential Oils against Staphylococcus aureus from Bovine Mastitis. Dairy. 2024; 5(1):54-65. https://doi.org/10.3390/dairy5010005

Chicago/Turabian Style

Munive Nuñez, Karen Vanessa, Anderson Clayton da Silva Abreu, Jaqueline Milagres de Almeida, Juliano Leonel Gonçalves, Érika Carolina Romão Bonsaglia, Marcos Veiga dos Santos, and Nathália Cristina Cirone Silva. 2024. "Antimicrobial Activity of Selected Essential Oils against Staphylococcus aureus from Bovine Mastitis" Dairy 5, no. 1: 54-65. https://doi.org/10.3390/dairy5010005

Article Metrics

Back to TopTop